Research Center for National New Vaccines Project_R&D Platforms_中国生物技术股份有限公司

Research Center for National New Vaccines Project

Co-funded by CNBG and Beijing Biological Products Institute Co., Ltd., the center was established in March 2005 with approval from National Development and Reform Commission. Its foundation came in the wake of the decision made by the CPC Central Committee and the State Council to build China into an innovative country. It is the only state-level R&D and production base for new-type vaccines in the country and a platform for relevant services. Its missions include: transforming conventional vaccines and solving key technological issues in the development and commercialization of new-type vaccines with modern biotechnologies; providing consulting services concerning R&D of new-type vaccines and biotechnologies; and providing an integrated technological platform for the engineering and commercialization of new-type vaccines developed in China through its viral vaccine platform, yeast protein expression platform, and insect protein expression platform, along with advanced manufacturing procedures and technologies in this area.

Research Center for National New Vaccines ProjectResearch Center for National New Vaccines ProjectResearch Center for National New Vaccines ProjectResearch Center for National New Vaccines Project